title: A validated spectrofluorometric assay for the determination of certain macrolide antibiotics in pharmaceutical formulations and spiked biological fluids.
abstract: This paper describes a simple spectrofluorometric method for the analysis of 4 macrolide antibiotics. The method is based on the condensation of 10% (w/v) malonic acid and acetic acid anhydride under the catalytic effect of tertiary amine groups of the studied macrolides. The relative fluorescence intensity of the condensation product was measured at 397/452 nm (excitation/emission) for azithromycin dihydrate and at 392/445 nm (for clarithromycin, erythromycin ethylsuccinate, and roxithromycin. All variables affecting the reaction conditions were studied. The effects of potential interference due to common excipients, such as starch, lactose, sucrose, glucose, gum acacia, and magnesium stearate, as well as trimethoprim and sulfisoxazole acetyl formulated in primomycin capsules and pediazole oral suspension, respectively, were studied. A validation study for the proposed method was carried out according to U.S. Pharmacopeia 2002. The linearity ranges were 3-80 ng/mL for all of the cited macrolides. The limit of detection range was 0.74-1.20 ng/mL, while the limit of quantitation range was 2.47-4.02 ng/mL. The method was applied for the assay of the studied macrolides in pure pharmaceutical formulations and in spiked biological fluids. Results were compared with those obtained from the reported method, where calculated t- and F-values indicated high accuracy and good precision for the proposed method.
authors.affiliation: Assiut University, Faculty of Pharmacy, Department of Pharmaceutical Analytical Chemistry, Assuit, Egypt.
authors.forename: Nawal
authors.initials: N
authors.lastname: El-Rabbat
authors.forename: Hassan F
authors.initials: HF
authors.lastname: Askal
authors.forename: Pakinaz Y
authors.initials: PY
authors.lastname: Khashaba
authors.forename: Noha N
authors.initials: NN
authors.lastname: Attia
mesh_terms: D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D017963:Azithromycin / Q000032:analysis; D002626:Chemistry, Pharmaceutical; D017291:Clarithromycin / Q000032:analysis; D015643:Erythromycin Ethylsuccinate / Q000032:analysis; D006801:Humans; D018942:Macrolides / Q000032:analysis* / Q000097:blood / Q000652:urine; D015575:Roxithromycin / Q000032:analysis; D012996:Solutions; D013050:Spectrometry, Fluorescence / Q000379:methods* / Q000706:statistics & numerical data
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D012996:Solutions; D015643:Erythromycin Ethylsuccinate; D015575:Roxithromycin; D017963:Azithromycin; D017291:Clarithromycin